Cat’s Claw (Uncaria tomentosa): The Amazonian Vine in Wellness Formulas

Cat’s claw is a climbing vine from the Amazon basin, named for the curved thorns along its stems. It has a serious place in Peruvian traditional medicine and a growing research literature — plus a chemistry detail that most labels never mention but that genuinely matters.

Botanical name
Uncaria tomentosa
Part used
Inner bark and root bark
Also found in
ProstaDefend
Cat’s Claw (Uncaria tomentosa)

What cat’s claw is

Uncaria tomentosa is a woody liana that climbs high into the canopy of the Amazon rainforest, found across Peru, Brazil, Ecuador, Colombia and neighbouring countries. Its Spanish name, uña de gato, comes from the pairs of curved thorns at the leaf nodes, which the plant uses to grip as it climbs.

The parts used are the inner bark of the vine and, in some preparations, the root bark. Harvesting is done by cutting sections of vine, which regrow, though pressure on wild populations has been an ongoing concern in Peru and has led to management regulations.

A closely related species, Uncaria guianensis, is also sold as cat’s claw and has a somewhat different chemistry. A third, entirely unrelated plant — the North American vine Macfadyena unguis-cati — shares the common name and is not the same thing.

Traditional use

Cat’s claw has a documented history in Asháninka and other Amazonian traditional practice, where decoctions of the bark are used for a range of complaints, notably inflammatory and digestive ones. The plant entered European awareness in the mid-twentieth century and has since become one of Peru’s better-known botanical exports.

Peru has regulated the harvest of Uncaria tomentosa to manage wild stocks, and cultivated material is increasingly available.

The two chemotypes — a detail worth knowing

This is the part that separates a well-made cat’s claw product from a careless one. Uncaria tomentosa occurs in two chemically distinct forms that look identical:

ChemotypeDominant alkaloidsWhy it matters
Pentacyclic oxindole (POA)Pteropodine, isopteropodine, mitraphylline and othersThe type used in most research and in quality-controlled products.
Tetracyclic oxindole (TOA)Rhynchophylline, isorhynchophyllineActs on different targets; some research suggests TOAs may counteract POA activity.

Because the two chemotypes cannot be told apart by eye, quality producers test raw material and specify a low TOA content. A label that says nothing about alkaloid profile is not necessarily bad, but it is telling you less.

What research has investigated

Most of the scientific work on cat’s claw is laboratory-based, examining its oxindole alkaloids and quinovic acid glycosides in relation to inflammatory signalling pathways and immune cell behaviour in culture.

Human trials exist but are limited in number and size. Several small studies looked at joint comfort over periods of a few months, using standardised extracts. Reviews of the area generally describe the human evidence as preliminary and call for larger trials.

Interest in cat’s claw for men’s formulas is largely about its studied role in inflammatory signalling as a general wellness contribution, rather than any prostate-specific research. That distinction is worth holding onto: being in a prostate formula is not the same as having been studied for the prostate.

The literature is indexed on PubMed.

Safety considerations

Cat’s claw has more interaction caveats than most botanicals on this list, and they are worth taking seriously.

  • Immunosuppressant medication. Cat’s claw has been studied for effects on immune cell activity. Anyone taking immunosuppressants — after a transplant, or for an autoimmune condition — should avoid it unless a specialist says otherwise.
  • Autoimmune conditions. For the same reason, caution is generally advised.
  • Blood pressure medication. Possible additive effects; check with a pharmacist.
  • Anticoagulants. Possible interaction; discuss before combining.
  • Medicines processed by the liver. There is evidence cat’s claw may affect certain cytochrome P450 enzymes, which is the mechanism behind many drug interactions. If you take regular prescription medication, this is a pharmacist conversation.
  • Pregnancy and breastfeeding. Not recommended.
  • Before surgery. Stop at least two weeks beforehand.

Reported side effects are usually mild — headache, dizziness or digestive upset.

How it appears in supplements

Standalone products commonly supply 250–350 mg of bark extract daily, sometimes standardised to a stated oxindole alkaloid percentage. In multi-ingredient men’s formulas such as ProstaDefend, cat’s claw is one of six botanicals sharing the daily two-capsule serving, so the amount is smaller.

When comparing products, look for the species named in full (Uncaria tomentosa, not just “cat’s claw”), the plant part, and ideally something about alkaloid standardisation.

Frequently asked questions

Who should not take cat’s claw?
Anyone on immunosuppressant medication, anyone with an autoimmune condition, anyone pregnant or breastfeeding, and anyone about to have surgery. It also has potential interactions with blood pressure medicines, anticoagulants and drugs metabolised by liver enzymes — worth a pharmacist check.
What is the difference between POA and TOA chemotypes?
They are two chemically distinct forms of the same species with different alkaloid profiles. Most research and most quality-controlled products use the pentacyclic (POA) type; some evidence suggests tetracyclic alkaloids may work against POA activity. The plants look identical, so only testing distinguishes them.
Is cat’s claw studied for prostate health specifically?
Not really. Its research base concerns inflammatory signalling and immune activity more generally. It appears in men’s formulas as a broad wellness ingredient, and it would be misleading to present it as prostate-specific.
Is cat’s claw sustainably harvested?
Peru regulates wild harvest of Uncaria tomentosa, and cultivated material is increasingly available. As with pygeum, sourcing is a fair question to ask a brand.
Is “cat’s claw” always the same plant?
No. Uncaria tomentosa and Uncaria guianensis are both sold under the name and differ chemically, and an unrelated North American vine shares the common name too. Look for the botanical name on the label.